Medicines Board backs Seroxat manufacturer’s defence of drug
The Irish Medicines Board today backed claims by the manufacturer of an anti-depressant that the benefits outweighed the risks.
Norwegian research suggests that adults who take Seroxat are being warned it can trigger suicidal feelings, while Makers GlaxoSmithKline are defending the drug.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





